Gene · 10057
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential therapeutic effects of milk-derived exosomes on intestinal diseases. | J Nanobiotechnology | 2023 | 38115131 | PubTator, text mining | PubMed |
| The Characteristics of Transcription Factors Regulating T Cell Exhaustion Were Analyzed to Predict the Prognosis and Therapeutic Effect in Patients with HCC. | Int J Gen Med | 2023 | 38045905 | PubTator, text mining | PubMed |
| Association of body mass index and PXDNL gene variants with acute primary angle closure in southern Chinese population. | Heliyon | 2023 | 38034647 | PubTator, text mining | PubMed |
| Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR. | Front Pharmacol | 2023 | 38026953 | PubTator, text mining | PubMed |
| Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness. | J Cancer Metastasis Treat | 2023 | 38009093 | PubTator, text mining | PubMed |
| A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy. | Pharmaceutics | 2023 | 38004602 | PubTator, text mining | PubMed |
| Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. | Pharmaceuticals (Basel) | 2023 | 38004447 | PubTator, text mining | PubMed |
| Molecular Biology and Clinical Management of Esophageal Adenocarcinoma. | Cancers (Basel) | 2023 | 38001670 | PubTator, text mining | PubMed |
| Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel. | Ann Med | 2023 | 37967237 | PubTator, text mining | PubMed |
| Down-Regulation of CYP3A4 by the KCa1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models. | Int J Mol Sci | 2023 | 37958656 | PubTator, text mining | PubMed |
| Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. | Nat Genet | 2023 | 37932435 | PubTator, text mining | PubMed |
| I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs. | Biomed Pharmacother | 2023 | 37913733 | PubTator, text mining | PubMed |
| Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer. | Biomed Rep | 2023 | 37901880 | PubTator, text mining | PubMed |
| Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS. | Cancers (Basel) | 2023 | 37894432 | PubTator, text mining | PubMed |
| Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease. | Cells | 2023 | 37887346 | PubTator, text mining | PubMed |
| Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. | Lipids Health Dis | 2023 | 37885013 | PubTator, text mining | PubMed |
| Erratum: [Corrigendum] Effects of histone deacetylase inhibitors on ATP‑binding cassette transporters in lung cancer A549 and colorectal cancer HCT116 cells. | Oncol Lett | 2023 | 37854869 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia. | Front Immunol | 2023 | 37854606 | PubTator, text mining | PubMed |
| Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance. | Cancers (Basel) | 2023 | 37835408 | PubTator, text mining | PubMed |
| Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. | Front Oncol | 2023 | 37810967 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10057/papers?page=5